Verified facts
- Approved labs can receive up to thirty free Business Standard seats for up to twelve months.
- GPT-Rosalind access remains subject to separate trusted-access approval; applying does not grant immediate access.
- Initial applications concern labs at US universities; teams covered by an Enterprise agreement follow their university’s process.
What changes
The program addresses access to scientific tools and seats, not new biomedical evidence.
Practical implication
Check geographic criteria before preparing an application.
Availability
Belgium/EEA: the described initial program targets US universities; eligibility for Belgian labs is not announced.
Limits and uncertainty
Scientific examples are usage testimonials, not clinical validations or guarantees of discovery.